UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 342

Sortiert nach

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Clinical chemistry (Baltimore, Md.), 2011-11, Vol.57 (11), p.1574-1583

2011

Link zum Volltext

Verfügbarkeit prüfen

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

Clinical pharmacokinetics, 2014-02, Vol.53 (2), p.123-139

2014

Link zum Volltext

Verfügbarkeit prüfen

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners

Genes, 2023-09, Vol.14 (10), p.1841

2023

Link zum Volltext

Verfügbarkeit prüfen

CYP2D64 polymorphism affects breast cancer survival in tamoxifen users

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.125-130

2009

Link zum Volltext

Verfügbarkeit prüfen

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.182-182, Article 182

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

British journal of cancer, 2018-05, Vol.118 (10), p.1296-1301

2018

Link zum Volltext

Verfügbarkeit prüfen

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

Clinical pharmacokinetics, 2018-10, Vol.57 (10), p.1229-1254

2018

Link zum Volltext

Verfügbarkeit prüfen

P450 oxidoreductase 28 (POR28) and tacrolimus disposition in pediatric kidney transplant recipients--a pilot study

Therapeutic drug monitoring, 2014-04, Vol.36 (2), p.152

2014

Link zum Volltext

Verfügbarkeit prüfen

Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000586

2020

Link zum Volltext

Verfügbarkeit prüfen

A genome-wide association study of acenocoumarol maintenance dosage

Human molecular genetics, 2009-10, Vol.18 (19), p.3758-3768

2009

Link zum Volltext

Verfügbarkeit prüfen

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Therapeutic drug monitoring, 2014-02, Vol.36 (1), p.71

2014

Link zum Volltext

Verfügbarkeit prüfen

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

Pharmacogenetics and genomics, 2010-01, Vol.20 (1), p.38-44

2010

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

European journal of human genetics : EJHG, 2020-04, Vol.28 (4), p.508-517

2020

Link zum Volltext

Verfügbarkeit prüfen

Personalized pharmacogenomics profiling using whole-genome sequencing

Pharmacogenomics, 2014-07, Vol.15 (9), p.1223-1234

2014

Link zum Volltext

Verfügbarkeit prüfen

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation

European journal of clinical pharmacology, 2011-12, Vol.67 (12), p.1231-1241

2011

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

The Journal of urology, 2011-05, Vol.185 (5), p.1650-1655

2011

Link zum Volltext

Verfügbarkeit prüfen

Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype

Pharmaceutical research, 2017-06, Vol.34 (6), p.1309-1319

2017

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

European journal of human genetics : EJHG, 2024-03, Vol.32 (3), p.278-285

2024

Link zum Volltext

Verfügbarkeit prüfen

Genetic Polymorphism as a Possible Cause of Severe Postoperative Pain

Journal of clinical pharmacology, 2024-03, Vol.64 (3), p.378-381

2024

Link zum Volltext

Verfügbarkeit prüfen

Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus

Therapeutic drug monitoring, 2013-08, Vol.35 (4), p.459

2013

Link zum Volltext

Verfügbarkeit prüfen

PharmVar GeneFocus: CYP3A5

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1159-1171

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics in Psychiatry: An Update on Clinical Usability

Frontiers in pharmacology, 2020-09, Vol.11, p.575540-575540

2020

Link zum Volltext

Verfügbarkeit prüfen

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

European urology, 2010-06, Vol.57 (6), p.921-927

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners

CYP2D64 polymorphism affects breast cancer survival in tamoxifen users

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

P450 oxidoreductase 28 (POR28) and tacrolimus disposition in pediatric kidney transplant recipients--a pilot study

Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

A genome-wide association study of acenocoumarol maintenance dosage

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

Personalized pharmacogenomics profiling using whole-genome sequencing

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

Genetic Polymorphism as a Possible Cause of Severe Postoperative Pain

Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus

PharmVar GeneFocus: CYP3A5

Pharmacogenetics in Psychiatry: An Update on Clinical Usability

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

Suchergebnisse filtern